Engineered mammalian and bacterial extracellular vesicles as promising nanocarriers for targeted therapy
2022

Engineered Extracellular Vesicles for Targeted Therapy

publication Evidence: moderate

Author Information

Author(s): Liu Han, Geng Zhen, Su Jiacan

Primary Institution: Institute of Translational Medicine, Shanghai University, Shanghai 200444, China

Hypothesis

Can engineered mammalian and bacterial extracellular vesicles improve targeted therapy for various diseases?

Conclusion

Engineered extracellular vesicles show promise as effective nanocarriers for targeted therapy in cancer and neurodegenerative diseases.

Supporting Evidence

  • Extracellular vesicles can carry various biomolecules to affect recipient cells.
  • Engineered vesicles can improve targeting ability and therapeutic effects.
  • Applications include cancer treatment and therapies for brain and bone diseases.

Takeaway

Scientists are using tiny bubbles called extracellular vesicles to deliver medicine directly to sick cells, making treatments more effective and safer.

Methodology

This review summarizes the biogenesis, isolation, characterization, and engineering techniques of mammalian and bacterial extracellular vesicles.

Limitations

Natural extracellular vesicles have poor targeting ability, which limits their therapeutic effectiveness.

Digital Object Identifier (DOI)

10.20517/evcna.2022.04

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication